Hitting the target: measuring EGFR response to tyrosine kinase inhibitors.
Nyati
Mukesh K
MK
Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0010, USA. nyati@med.umich.edu
Lawrence
Theodore S
TS
D003106:Colon / Q000737:chemistry*; D015179:Colorectal Neoplasms / Q000737:chemistry*; D004797:Enzyme-Linked Immunosorbent Assay; D066246:ErbB Receptors / Q000032:analysis* / Q000037:antagonists & inhibitors* / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000295:instrumentation / Q000379:methods; D015151:Immunoblotting; D007150:Immunohistochemistry; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors; D000077156:Gefitinib